Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis

Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis

US Patent 11267779 · Granted Mar 8, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Plasminogen treatment of conditions associated with PAI-1 overexpression2023
Plasminogen treatment of conditions associated with PAI-1 overexpression2023
Plasminogen treatment of conditions associated with PAI-1 overexpression2023
Substituted aromatic compounds and related method for the treatment of fibrosis2022
Substituted aromatic compounds and related method for the treatment of fibrosis2022
Substituted aromatic compounds and related method for the treatment of fibrosis2022
Plasminogen replacement therapy for plasminogen-deficiency2022
Substituted aromatic compounds and pharmaceutical compositions for the preventio2021
Substituted aromatic compounds and pharmaceutical compositions for the preventio2021
Phenylketone carboxylate compounds and pharmaceutical compositions for the preve2021
Phenylketone carboxylate compounds and pharmaceutical compositions for the preve2021
Substituted aromatic compounds and pharmaceutical compositions for tissue self-r2020